Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Neuro-Oncology Advances|December 22, 2023
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivityMaikel Verduin, Linde Hoosemans, Maxime Vanmechelen, et al.
The Oncologist|December 18, 2023
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery ProtocolIlse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery ProtocolKarlijn Verkerk, Tijmen J W T van der Wel, Laurien J Zeverijn, et al.
JAMA Otolaryngology-- Head & Neck Surgery|May 8, 2025
A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM ClassificationShao Hui Huang, Jie Su, Shlomo A Koyfman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery ProtocolBirgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, et al.
Acta Oncologica (Stockholm, Sweden)|April 23, 2020
A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancerJudith de Vos-Geelen, Frank J P Hoebers, Sandra M E Geurts, et al.
Cell Reports. Medicine|October 26, 2020
Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of GlioblastomaNik Sol, Sjors G J G In 't Veld, Adrienne Vancura, et al.
Cancer Cell|March 10, 2023
Transcriptome analysis reveals tumor microenvironment changes in glioblastomaYouri Hoogstrate, Kaspar Draaisma, Santoesha A Ghisai, et al.
Cancers|February 13, 2021
Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in GlioblastomaMaikel Verduin, Sergey Primakov, Inge Compter, et al.
BMC Cancer|March 4, 2023
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumoursBirgit S Geurts, Thomas W Battaglia, J Maxime van Berge Henegouwen, et al.
Pageof 8